...
首页> 外文期刊>Journal of Neurology >Low-dose idebenone treatment in Friedreich’s ataxia with and without cardiac hypertrophy
【24h】

Low-dose idebenone treatment in Friedreich’s ataxia with and without cardiac hypertrophy

机译:弗雷德里希共济失调伴或不伴心脏肥大的小剂量艾地苯醌治疗

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Left ventricular hypertrophy (LVH) is a frequent finding in Friedreich’s ataxia (FRDA). In previous studies treatment with idebenone, a synthetic analogue of coenzyme Q10, has been associated with a substantial decrease in myocardial hypertrophy, despite great variability in cardiac responsiveness among patients. Here we present the results of a retrospective analysis of a cohort of 35 patients (20 with LVH, 15 without LVH) with confirmed molecular diagnosis of FRDA, treated with idebenone 5 mg/kg/day for up to five years. At the end of the study, we found an increase of interventricular septum and posterior wall thickness in the group without LVH before treatment and no change in the group with LVH before treatment. The neurological picture of the disease significantly deteriorated with time in both groups.
机译:弗里德里希共济失调(FRDA)经常发现左心室肥大(LVH)。在先前的研究中,尽管艾迪苯醌是辅酶Q10的合成类似物,但尽管患者的心脏反应性差异很大,但它与心肌肥大的显着降低有关。在此,我们对35例经确诊为FRDA的分子确诊为FRDA的35例患者(20例行LVH,15例不行LVH)进行回顾性分析,结果用艾地苯醌5 mg / kg /天治疗长达五年。在研究结束时,我们发现治疗前无LVH的组室间隔和后壁厚度增加,治疗前无LVH的组无变化。在两组中,随着时间的流逝,该疾病的神经学图像均明显恶化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号